Jeff Dean, who for years was one of Google’s most important executives, is leading the new artificial intelligence company with the backing of Google. By Cade Metz Reporting from Palo Alto, Calif.

Crypto exchanges are rapidly expanding into traditional finance by offering perpetual futures tied to stocks, indexes and commodities, with trading volume surging to $1.32 trillion in the first five ...

SEATTLE — At the end of the day — a day before the most significant match in U.S. men’s soccer history — justice was served. Folarin Balogun, the dynamic U.S. striker who’s scored a goal in each of ...

On Friday, Claude Code creator Boris Cherny made an appearance at Meta’s @Scale conference and, surprisingly, the first question from the audience was about loops. “Are loops the next hype cycle,” the ...

The program takes aim at the industry profiting off one of America's most expensive chronic conditions. AUSTIN, Texas, June 8, 2026 /PRNewswire/ -- CrowdHealth today announced the launch of a ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Anthropic reveals that Claude now writes over 80% of its production code, with engineers shipping 8x more code per quarter than in 2024. The company’s new Anthropic Institute paper maps the path to ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Richard Socher has been a major figure in AI for some time, best known for founding the early chatbot startup You.com and, before that, his work on ImageNet. Now he’s joining the current generation of ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated ...